
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Medidata has announced that it has launched the Medidata Institute. The Institute will aim to deliver insights that redefine how technology, data, and artificial intelligence may improve and inspire the next generation of medical treatments. Initial partnerships of the Medidata Institute are with Castleman Disease Collaborative Network and Friends of Cancer Research deliver insights.
For more information, click






